Recombinant human gelsolin promotes the migration of human articular cartilage chondrocytes by regulating gene expression in vitro. Issue 4 (December 2020)

• Record Type: Journal Article
• Authors: Feldt, Jessica; Welss, Jessica; Schropp, Verena; Gelse, Kolja; Tsokos, Michael; Paulsen, Friedrich
• Is Part Of: Osteoarthritis and cartilage open. Volume 2:Issue 4(2020)
• Publication Date: 2020-12
• Subjects: Gelsolin -- Chondrocytes -- Osteoarthritis -- Migration -- Wound closure; Osteoarthritis -- Periodicals; Cartilage -- Periodicals; 616.7223005
• DOI: 10.1016/j.ocarto.2020.100124
• Languages: English
• ISSNs: 2665-9131

Abstract

Abstract: Objective: It is known that recombinant human gelsolin (rhuGSN) supports wound closure and migration processes in avascular tissue. Since articular cartilage degradation plays an important role in osteoarthritis (OA), we are investigating how rhuGSN affects regeneration processes in human articular cartilage and represents a promising new therapeutic approach for the treatment of OA. Methods: Primary human chondrocytes (phCs) from articular knee cartilage were cultured with different concentrations of rhuGSN to analyse its direct effect in vitro . In addition, phCs were stimulated with 10 ng/mL IL-1β or TNF-α to simulate osteoarthritis in vitro and treated with different concentrations of rhuGSN to investigate the beneficial effect in disease treatment. Cytokine secretion and gene expression as well as wound assays were performed. Results: GSN significantly promotes wound closure in phCs after 60 h compared to untreated cells. After 24 h treatment with 30 μg/mL rhuGSN, TGF-β secretion increases significantly in the in vitro osteoarthritis model. Gene expression of MMP1 as well as SPARC is reduced in chondrocytes due to treatment with GSN in the OA model. At the same time, CXCR4 expression increases significantly after 24 h treatment with 3 μg/mL GSN. Conclusion: In the in vitro model of osteoarthritis, rhuGSN promotes wound closure of chondrocytes by a supported migration as well as expression of reconstructive and down regulated expression of deconstructive genes concentration dependently. Further experiments are needed to fully understand the beneficial effect of gelsolin on human chondrocytes and to verify this promising approach for a pharmacological treatment of osteoarthritis.